BLOOD?ITS DERIVATIVES AND ITS PROBLEMS?FACTOR VIII
- 1 January 1975
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 240 (1) , 165-171
- https://doi.org/10.1111/j.1749-6632.1975.tb53341.x
Abstract
Unfortunately, all of the problems of the hemophiliac have not been solved by the availability of concentrated factor VIII products. Patients still are faced with the crippling effects of arthritis, problems with employment, problems with ignorance (both medical and lay), and an increased risk of premature death even in a sophisticated, treatment-oriented, community (Table 3). It can only be hoped that we can solve the problems of hepatitis transmission, availability, and economics so that concentrated forms of factor VIII can be made available to all patients with hemophilia. It seems appropriate to suggest that our severely affected patients should be placed on some prophylactic programs, since this would ease most of the long-term psychologic and physical disabilities common to this disease.Keywords
This publication has 22 references indexed in Scilit:
- Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive DonorsAnnals of Internal Medicine, 1972
- Hemophilia hometransfusion program: Effect on school attendanceThe Journal of Pediatrics, 1972
- Acute Anemia with Factor VIII TherapyAnnals of Internal Medicine, 1972
- Can Hemophilic Patients Be Adequately Maintained with Cryoprecipitates? Or Is it Desirable or Even Necessary to Manufacture and Administer Highly Concentrated AHF Products?Vox Sanguinis, 1972
- The Use of Factor VIII and Factor IX Concentrates During SurgeryPublished by American Medical Association (AMA) ,1970
- Antihemophilic factor 8 in hemophilia. Use of concentrates to permit major surgeryJAMA, 1970
- The Physiologic Basis for Therapy of Classic Hemophilia (Factor VIII Deficiency) and Related DisordersAnnals of Internal Medicine, 1967
- TREATMENT OF HÆMOPHILIA (FACTOR-VIII DEFICIENCY) WITH HUMAN ANTIHÆMOPHILIC FACTOR PREPARED BY THE CRYOPRECIPITATE PROCESSThe Lancet, 1967
- Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag SystemNew England Journal of Medicine, 1965
- HÆMORRHAGIC DIATHESIS.The Lancet, 1840